• レポートコード:QYR2104Z3559 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、127ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品、ヘルスケア |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、海洋生物製剤のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(医薬品、健康補助食品)、用途別市場規模(病院・クリニック、薬局、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・海洋生物製剤の市場動向 ・企業の競争状況、市場シェア ・海洋生物製剤の種類別市場規模(医薬品、健康補助食品) ・海洋生物製剤の用途別市場規模(病院・クリニック、薬局、その他) ・海洋生物製剤の北米市場規模2016-2027(アメリカ、カナダ) ・海洋生物製剤のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・海洋生物製剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・海洋生物製剤の中南米市場規模2016-2027(メキシコ、ブラジル) ・海洋生物製剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Seattle Genetics、DSM、Eisai Co、Takeda、BASF、Amway、Pfizer、Pelagia (EPAX)、Pharma Mar SA、Croda、GNC、GSK、TerSera Therapeutics、Nordic Naturals、Carlson Labs) ・結論 |
Market Analysis and Insights: Global Marine Biopharmaceutical Market
The global Marine Biopharmaceutical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Marine Biopharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Marine Biopharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Marine Biopharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Marine Biopharmaceutical market.
Global Marine Biopharmaceutical Scope and Market Size
Marine Biopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marine Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drugs
Health Supplement
Segment by Application
Hospital & Clinic
Pharmacy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Takeda
BASF
GSK
TerSera Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Health Supplement
1.3 Market by Application
1.3.1 Global Marine Biopharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Marine Biopharmaceutical Market Perspective (2016-2027)
2.2 Marine Biopharmaceutical Growth Trends by Regions
2.2.1 Marine Biopharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Marine Biopharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Marine Biopharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Marine Biopharmaceutical Industry Dynamic
2.3.1 Marine Biopharmaceutical Market Trends
2.3.2 Marine Biopharmaceutical Market Drivers
2.3.3 Marine Biopharmaceutical Market Challenges
2.3.4 Marine Biopharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Marine Biopharmaceutical Players by Revenue
3.1.1 Global Top Marine Biopharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Marine Biopharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Marine Biopharmaceutical Revenue
3.4 Global Marine Biopharmaceutical Market Concentration Ratio
3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2020
3.5 Marine Biopharmaceutical Key Players Head office and Area Served
3.6 Key Players Marine Biopharmaceutical Product Solution and Service
3.7 Date of Enter into Marine Biopharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Marine Biopharmaceutical Breakdown Data by Type
4.1 Global Marine Biopharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Marine Biopharmaceutical Forecasted Market Size by Type (2022-2027)
5 Marine Biopharmaceutical Breakdown Data by Application
5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Marine Biopharmaceutical Market Size (2016-2027)
6.2 North America Marine Biopharmaceutical Market Size by Type
6.2.1 North America Marine Biopharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Marine Biopharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Marine Biopharmaceutical Market Size by Type (2016-2027)
6.3 North America Marine Biopharmaceutical Market Size by Application
6.3.1 North America Marine Biopharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Marine Biopharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Marine Biopharmaceutical Market Size by Application (2016-2027)
6.4 North America Marine Biopharmaceutical Market Size by Country
6.4.1 North America Marine Biopharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Marine Biopharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Marine Biopharmaceutical Market Size (2016-2027)
7.2 Europe Marine Biopharmaceutical Market Size by Type
7.2.1 Europe Marine Biopharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Marine Biopharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Marine Biopharmaceutical Market Size by Type (2016-2027)
7.3 Europe Marine Biopharmaceutical Market Size by Application
7.3.1 Europe Marine Biopharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Marine Biopharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Marine Biopharmaceutical Market Size by Application (2016-2027)
7.4 Europe Marine Biopharmaceutical Market Size by Country
7.4.1 Europe Marine Biopharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Marine Biopharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Marine Biopharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type
8.2.1 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application
8.3.1 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Marine Biopharmaceutical Market Size by Region
8.4.1 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Marine Biopharmaceutical Market Size (2016-2027)
9.2 Latin America Marine Biopharmaceutical Market Size by Type
9.2.1 Latin America Marine Biopharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Marine Biopharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Marine Biopharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Marine Biopharmaceutical Market Size by Application
9.3.1 Latin America Marine Biopharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Marine Biopharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Marine Biopharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Marine Biopharmaceutical Market Size by Country
9.4.1 Latin America Marine Biopharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Marine Biopharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Marine Biopharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type
10.2.1 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application
10.3.1 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Marine Biopharmaceutical Market Size by Country
10.4.1 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Seattle Genetics
11.1.1 Seattle Genetics Company Details
11.1.2 Seattle Genetics Business Overview
11.1.3 Seattle Genetics Marine Biopharmaceutical Introduction
11.1.4 Seattle Genetics Revenue in Marine Biopharmaceutical Business (2016-2021)
11.1.5 Seattle Genetics Recent Development
11.2 DSM
11.2.1 DSM Company Details
11.2.2 DSM Business Overview
11.2.3 DSM Marine Biopharmaceutical Introduction
11.2.4 DSM Revenue in Marine Biopharmaceutical Business (2016-2021)
11.2.5 DSM Recent Development
11.3 Eisai Co
11.3.1 Eisai Co Company Details
11.3.2 Eisai Co Business Overview
11.3.3 Eisai Co Marine Biopharmaceutical Introduction
11.3.4 Eisai Co Revenue in Marine Biopharmaceutical Business (2016-2021)
11.3.5 Eisai Co Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Marine Biopharmaceutical Introduction
11.4.4 Takeda Revenue in Marine Biopharmaceutical Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 BASF
11.5.1 BASF Company Details
11.5.2 BASF Business Overview
11.5.3 BASF Marine Biopharmaceutical Introduction
11.5.4 BASF Revenue in Marine Biopharmaceutical Business (2016-2021)
11.5.5 BASF Recent Development
11.6 Amway
11.6.1 Amway Company Details
11.6.2 Amway Business Overview
11.6.3 Amway Marine Biopharmaceutical Introduction
11.6.4 Amway Revenue in Marine Biopharmaceutical Business (2016-2021)
11.6.5 Amway Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Marine Biopharmaceutical Introduction
11.7.4 Pfizer Revenue in Marine Biopharmaceutical Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Pelagia (EPAX)
11.8.1 Pelagia (EPAX) Company Details
11.8.2 Pelagia (EPAX) Business Overview
11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Introduction
11.8.4 Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2016-2021)
11.8.5 Pelagia (EPAX) Recent Development
11.9 Pharma Mar SA
11.9.1 Pharma Mar SA Company Details
11.9.2 Pharma Mar SA Business Overview
11.9.3 Pharma Mar SA Marine Biopharmaceutical Introduction
11.9.4 Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2016-2021)
11.9.5 Pharma Mar SA Recent Development
11.10 Croda
11.10.1 Croda Company Details
11.10.2 Croda Business Overview
11.10.3 Croda Marine Biopharmaceutical Introduction
11.10.4 Croda Revenue in Marine Biopharmaceutical Business (2016-2021)
11.10.5 Croda Recent Development
11.11 GNC
11.11.1 GNC Company Details
11.11.2 GNC Business Overview
11.11.3 GNC Marine Biopharmaceutical Introduction
11.11.4 GNC Revenue in Marine Biopharmaceutical Business (2016-2021)
11.11.5 GNC Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Marine Biopharmaceutical Introduction
11.12.4 GSK Revenue in Marine Biopharmaceutical Business (2016-2021)
11.12.5 GSK Recent Development
11.13 TerSera Therapeutics
11.13.1 TerSera Therapeutics Company Details
11.13.2 TerSera Therapeutics Business Overview
11.13.3 TerSera Therapeutics Marine Biopharmaceutical Introduction
11.13.4 TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2016-2021)
11.13.5 TerSera Therapeutics Recent Development
11.14 Nordic Naturals
11.14.1 Nordic Naturals Company Details
11.14.2 Nordic Naturals Business Overview
11.14.3 Nordic Naturals Marine Biopharmaceutical Introduction
11.14.4 Nordic Naturals Revenue in Marine Biopharmaceutical Business (2016-2021)
11.14.5 Nordic Naturals Recent Development
11.15 Carlson Labs
11.15.1 Carlson Labs Company Details
11.15.2 Carlson Labs Business Overview
11.15.3 Carlson Labs Marine Biopharmaceutical Introduction
11.15.4 Carlson Labs Revenue in Marine Biopharmaceutical Business (2016-2021)
11.15.5 Carlson Labs Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Health Supplement
Table 4. Global Marine Biopharmaceutical Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Marine Biopharmaceutical Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Marine Biopharmaceutical Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Marine Biopharmaceutical Market Share by Regions (2016-2021)
Table 8. Global Marine Biopharmaceutical Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Marine Biopharmaceutical Market Share by Regions (2022-2027)
Table 10. Marine Biopharmaceutical Market Trends
Table 11. Marine Biopharmaceutical Market Drivers
Table 12. Marine Biopharmaceutical Market Challenges
Table 13. Marine Biopharmaceutical Market Restraints
Table 14. Global Marine Biopharmaceutical Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Marine Biopharmaceutical Market Share by Players (2016-2021)
Table 16. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marine Biopharmaceutical as of 2020)
Table 17. Ranking of Global Top Marine Biopharmaceutical Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Marine Biopharmaceutical Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Marine Biopharmaceutical Product Solution and Service
Table 21. Date of Enter into Marine Biopharmaceutical Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Marine Biopharmaceutical Revenue Market Share by Type (2016-2021)
Table 25. Global Marine Biopharmaceutical Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Marine Biopharmaceutical Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Marine Biopharmaceutical Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Marine Biopharmaceutical Revenue Market Share by Application (2016-2021)
Table 29. Global Marine Biopharmaceutical Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Marine Biopharmaceutical Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Marine Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Marine Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Marine Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Marine Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Marine Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Marine Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Marine Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Marine Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Marine Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Marine Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Marine Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Marine Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Marine Biopharmaceutical Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Marine Biopharmaceutical Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Marine Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Marine Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Marine Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Marine Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Marine Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Marine Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Marine Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Marine Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Marine Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 61. Seattle Genetics Company Details
Table 62. Seattle Genetics Business Overview
Table 63. Seattle Genetics Marine Biopharmaceutical Product
Table 64. Seattle Genetics Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 65. Seattle Genetics Recent Development
Table 66. DSM Company Details
Table 67. DSM Business Overview
Table 68. DSM Marine Biopharmaceutical Product
Table 69. DSM Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 70. DSM Recent Development
Table 71. Eisai Co Company Details
Table 72. Eisai Co Business Overview
Table 73. Eisai Co Marine Biopharmaceutical Product
Table 74. Eisai Co Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 75. Eisai Co Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Marine Biopharmaceutical Product
Table 79. Takeda Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 80. Takeda Recent Development
Table 81. BASF Company Details
Table 82. BASF Business Overview
Table 83. BASF Marine Biopharmaceutical Product
Table 84. BASF Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 85. BASF Recent Development
Table 86. Amway Company Details
Table 87. Amway Business Overview
Table 88. Amway Marine Biopharmaceutical Product
Table 89. Amway Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 90. Amway Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Marine Biopharmaceutical Product
Table 94. Pfizer Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Pelagia (EPAX) Company Details
Table 97. Pelagia (EPAX) Business Overview
Table 98. Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 99. Pelagia (EPAX) Recent Development
Table 100. Pharma Mar SA Company Details
Table 101. Pharma Mar SA Business Overview
Table 102. Pharma Mar SA Marine Biopharmaceutical Product
Table 103. Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 104. Pharma Mar SA Recent Development
Table 105. Croda Company Details
Table 106. Croda Business Overview
Table 107. Croda Marine Biopharmaceutical Product
Table 108. Croda Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 109. Croda Recent Development
Table 110. GNC Company Details
Table 111. GNC Business Overview
Table 112. GNC Marine Biopharmaceutical Product
Table 113. GNC Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 114. GNC Recent Development
Table 115. GSK Company Details
Table 116. GSK Business Overview
Table 117. GSK Marine Biopharmaceutical Product
Table 118. GSK Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 119. GSK Recent Development
Table 120. TerSera Therapeutics Company Details
Table 121. TerSera Therapeutics Business Overview
Table 122. TerSera Therapeutics Marine Biopharmaceutical Product
Table 123. TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 124. TerSera Therapeutics Recent Development
Table 125. Nordic Naturals Company Details
Table 126. Nordic Naturals Business Overview
Table 127. Nordic Naturals Marine Biopharmaceutical Product
Table 128. Nordic Naturals Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 129. Nordic Naturals Recent Development
Table 130. Carlson Labs Company Details
Table 131. Carlson Labs Business Overview
Table 132. Carlson Labs Marine Biopharmaceutical Product
Table 133. Carlson Labs Revenue in Marine Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 134. Carlson Labs Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Marine Biopharmaceutical Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Health Supplement Features
Figure 4. Global Marine Biopharmaceutical Market Share by Application: 2020 VS 2027
Figure 5. Hospital & Clinic Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Other Case Studies
Figure 8. Marine Biopharmaceutical Report Years Considered
Figure 9. Global Marine Biopharmaceutical Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Marine Biopharmaceutical Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Marine Biopharmaceutical Market Share by Regions: 2020 VS 2027
Figure 12. Global Marine Biopharmaceutical Market Share by Regions (2022-2027)
Figure 13. Global Marine Biopharmaceutical Market Share by Players in 2020
Figure 14. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marine Biopharmaceutical as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Marine Biopharmaceutical Revenue in 2020
Figure 16. Global Marine Biopharmaceutical Revenue Market Share by Type (2016-2021)
Figure 17. Global Marine Biopharmaceutical Revenue Market Share by Type (2022-2027)
Figure 18. North America Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Marine Biopharmaceutical Market Share by Type (2016-2027)
Figure 20. North America Marine Biopharmaceutical Market Share by Application (2016-2027)
Figure 21. North America Marine Biopharmaceutical Market Share by Country (2016-2027)
Figure 22. United States Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Marine Biopharmaceutical Market Share by Type (2016-2027)
Figure 26. Europe Marine Biopharmaceutical Market Share by Application (2016-2027)
Figure 27. Europe Marine Biopharmaceutical Market Share by Country (2016-2027)
Figure 28. Germany Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Marine Biopharmaceutical Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Marine Biopharmaceutical Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Marine Biopharmaceutical Market Share by Region (2016-2027)
Figure 38. China Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Marine Biopharmaceutical Market Share by Type (2016-2027)
Figure 46. Latin America Marine Biopharmaceutical Market Share by Application (2016-2027)
Figure 47. Latin America Marine Biopharmaceutical Market Share by Country (2016-2027)
Figure 48. Mexico Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Marine Biopharmaceutical Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Marine Biopharmaceutical Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Marine Biopharmaceutical Market Share by Country (2016-2027)
Figure 54. Turkey Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Marine Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Seattle Genetics Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 58. DSM Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 59. Eisai Co Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 60. Takeda Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 61. BASF Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 62. Amway Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 64. Pelagia (EPAX) Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 65. Pharma Mar SA Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 66. Croda Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 67. GNC Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 69. TerSera Therapeutics Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 70. Nordic Naturals Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 71. Carlson Labs Revenue Growth Rate in Marine Biopharmaceutical Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed